Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

Clicks: 252
ID: 272247
2006
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Oral MPT is an effective first-line treatment for elderly patients with multiple myeloma. Anticoagulant prophylaxis reduces frequency of thrombosis. Longer follow-up is needed to assess effect on overall survival.
Reference Key
a2006lancetoral Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Palumbo A;Bringhen S;Caravita T;Merla E;Capparella V;Callea V;Cangialosi C;Grasso M;Rossini F;Galli M;Catalano L;Zamagni E;Petrucci MT;De Stefano V;Ceccarelli M;Ambrosini MT;Avonto I;Falco P;Ciccone G;Liberati AM;Musto P;Boccadoro M; ;;
Journal Lancet (London, England)
Year 2006
DOI
DOI not found
URL
https://www.pubmed.gov/16530576/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male aged middle aged 80 and over Randomized Controlled Trial Multicenter Study sara bringhen disease-free survival melphalan / administration & dosage prednisone / administration & dosage antineoplastic agents investigators=[] affs=[]) antonio palumbo multiple myeloma / drug therapy* multiple myeloma / mortality thalidomide / administration & dosage pmid:16530576 doi:10.1016/s0140-6736(06)68338-4 collabauthor(name='italian multiple myeloma network gimema' alkylating / administration & dosage hormonal / administration & dosage antineoplastic combined chemotherapy protocols*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.